Hospital de Base

Hospital de Base de São José do Rio Preto (HB) is a premier healthcare and research institution in Brazil, serving as the primary teaching hospital for the Faculty of Medicine of Rio Preto (FAMERP). Managed by the FUNFARME foundation, the hospital operates the Integrated Research Center (CIP), recognized as one of the largest and most sophisticated clinical research facilities in Latin America. HB is a critical hub for international multicenter clinical trials, partnering with global pharmaceutical leaders such as Amgen, Merck, Pfizer, and AstraZeneca to advance treatments in oncology, cardiology, and infectious diseases. The institution provides high-complexity medical services to a population of over 1.5 million and is a cornerstone of the Brazilian Unified Health System (SUS), integrating advanced clinical care with robust scientific investigation.